Scientific work

Uzm. Dr. Zekeriya Hannarici

30 publications. The source of the information is stated next to each publication.

Back to profile

  1. Distinguishing adrenal metastases from benign lesions in NSCLC: the value of clinical and radiological parameters

    BMC cancer, 2026

    DOI 10.1186/s12885-026-15878-7 PMID 41851668 Open-access full textSource: Europe PMC

  2. Comparison of Anthracycline-Containing and Anthracycline-Free Neoadjuvant Regimens in HER2-Positive Breast Cancer

    Research Square, 2026

    DOI 10.21203/rs.3.rs-8673435/v1 Open-access full textSource: OpenAlex

  3. Comparison of anthracycline-containing and anthracycline-free neoadjuvant regimens in HER2-positive breast cancer.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e13021 Source: OpenAlex

  4. Prognostic Value of the Gustave Roussy Immune Score in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy: A Retrospective Cohort Study

    Diagnostics (Basel, Switzerland), 2026

    DOI 10.3390/diagnostics16121759 PMID 42351419 Open-access full textSource: Europe PMC

  5. Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center Study

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15124502 PMID 42355670 Open-access full textSource: Europe PMC

  6. Prognostic Value of Albumin-to-CEA Ratio in Metastatic Colorectal Cancer: A Retrospective Study

    Biomedicines, 2026

    DOI 10.3390/biomedicines14030579 PMID 41898226 Open-access full textSource: Europe PMC

  7. Parameters That May Predict NAC Effectiveness in Hormone-Positive Breast Cancer According to CPS Score

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s569515 PMID 41859752 Open-access full textSource: OpenAlex

  8. The impact of digital health technology use on oncology-specific clinical guideline adherence among medical oncologists in Turkiye

    Anatolian Current Medical Journal, 2026

    DOI 10.38053/acmj.1943411 Open-access full textSource: OpenAlex

  9. Adjuvant chemotherapy patterns and clinicopathological factors associated with survival in patients aged 70 years and older with resected stage II–III colon cancer: a single-center real-world study

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1959390 Open-access full textSource: OpenAlex

  10. APPROACH TO METASTATIC ADRENAL MASSES

    Turkiye Klinikleri eBooks, 2026

    DOI 10.5336/978-625-5439-07-9_p141 Source: OpenAlex

  11. Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy

    Diagnostics (Basel, Switzerland), 2025

    DOI 10.3390/diagnostics15243158 PMID 41464158 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  12. The Relationship Between Vitamin D and Euthyroid Sick Syndrome in Hospitalized Solid Cancer Patients: A Retrospective Study

    Clinical Medicine Insights Oncology, 2025

    DOI 10.1177/11795549251359147 PMID 40735466 Open-access full textSource: OpenAlex

  13. New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

    Düzce Tıp Fakültesi Dergisi, 2025

    DOI 10.18678/dtfd.1637275 Open-access full textSource: OpenAlex

  14. Survival Comparison and Clinical Characteristics of Sunitinib and Pazopanib in the Treatment of Metastatic Renal Cell Cancer, Single Center Real-Life Data

    Kafkas Journal of Medical Sciences, 2025

    DOI 10.5505/kjms.2025.98250 Open-access full textSource: OpenAlex

  15. Inflammatory parameters in NSCLC with driver mutation

    Lung cancer management, 2024

    DOI 10.2217/lmt-2023-0014 PMID 38818368 3 citations (Europe PMC) Open-access full textSource: Europe PMC

  16. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

    Breast Cancer: Targets and Therapy, 2024

    DOI 10.2147/bctt.s464161 PMID 38974895 8 citations (Europe PMC) Open-access full textSource: ORCID

  17. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

    BMC Cancer, 2024

    DOI 10.1186/s12885-024-12347-x PMID 38783223 7 citations (OpenAlex) Open-access full textSource: OpenAlex

  18. Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma

    Archives of Basic and Clinical Research, 2024

    DOI 10.5152/abcr.2024.23149 Open-access full textSource: OpenAlex

  19. Bilateral breast metastasis due to rectal cancer: A rare case report

    Open Journal of Clinical and Medical Case Reports, 2024

    DOI 10.52768/2379-1039/2197 Open-access full textSource: OpenAlex

  20. Mide kanserinde adropin ve hipoksi ile indüklenebilir faktör -1 alfa’nın önemi

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1442369 Open-access full textSource: OpenAlex

  21. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer

    Future oncology (London, England), 2023

    DOI 10.2217/fon-2022-0579 PMID 37125596 8 citations (Europe PMC) Source: Europe PMC

  22. The clinical significance and diagnostic value of serum Dickkopf1 and CKAP4 levels in patients with gastric cancer: a prospective study.

    PubMed, 2023

    DOI 10.26355/eurrev_202310_34183 PMID 37916373 2 citations (OpenAlex) Source: OpenAlex

  23. Evaluation of Clinical and Laboratory Factors Affecting Bone Mineral Density Measurements in Patients with Kidney Transplant

    Journal of Clinical Densitometry, 2022

    DOI 10.1016/j.jocd.2022.01.001 PMID 35168896 Source: OpenAlex

  24. Lipegfilgrastim may cause hyperleukocytosis

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022

    DOI 10.1177/10781552221082645 PMID 35200056 1 citation (Europe PMC) Source: Europe PMC

  25. Reply to John L. Frater’s letter to the editor: Use of laboratory hematology data in melanoma research: comments on ‘A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio’

    Melanoma Research, 2022

    DOI 10.1097/cmr.0000000000000829 PMID 35703446 Source: OpenAlex

  26. The Importance of the Glucose-To-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Treated with Sorafenib

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0457 PMID 34431372 18 citations (Europe PMC) Source: OpenAlex

  27. Onkolojik Aciller

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.352 Source: ORCID

  28. Onkolojide Destek Tedaviler ve Semptom Yönetimi

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.180 Source: OpenAlex

  29. A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio

    Melanoma Research, 2021

    DOI 10.1097/cmr.0000000000000785 PMID 34570023 5 citations (OpenAlex) Source: OpenAlex

  30. Evaluation of Clinical and Laboratory Parameters Affecting Measurements of Bone Mineral Densitometry in Renal Transplantation Patients

    Endocrinology research and practice., 2018

    DOI 10.25179/tjem.20182202-p110 Open-access full textSource: OpenAlex